Ulta Beauty SVP awarded options and stock grant

Ulta Beauty senior executive Christopher Lialios received new equity awards, increasing his direct stake in the company.

Rhea-AI Filing Summary

Ulta Beauty senior executive Christopher Lialios received new equity awards, increasing his direct stake in the company. On March 31, 2026, he was granted options to buy 757 shares of Ulta Beauty common stock at an exercise price of $522.71 per share, expiring on March 31, 2036. These options vest in 25% annual increments beginning March 15, 2027 through March 15, 2030. He also received 519 shares of restricted stock that vest 100% on March 15, 2029. Following the restricted stock grant, his direct common stock holdings total 3,550 shares.

Insider Trade Summary

Grant/Award: 1,276 shares

Grant/Award 2 txns

Insider Lialios Christopher

Role SVP, Controller (P. Acct Ofc.)

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	757	$0.00	$0.00
Grant/Award	Common Stock	519	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 757 contracts (Direct); Common Stock — 3,550 shares (Direct)

Footnotes (2)

1. F1. Represents grant of 519 shares of restricted stock, vesting 100% on March 15, 2029.
2. F2. The options, representing an initial right to purchase a total of 757 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.

Key Figures

Stock options granted: 757 options Option exercise price: $522.71 per share Option expiration: March 31, 2036 +5 more

8 metrics

Stock options granted 757 options Grant on March 31, 2026, right to buy common stock

Option exercise price $522.71 per share Exercise price for 757 stock options

Option expiration March 31, 2036 Expiration date of granted stock options

Restricted shares granted 519 shares Restricted stock grant on March 31, 2026

Restricted stock vesting date March 15, 2029 100% vesting of 519 restricted shares

Post-grant common holdings 3,550 shares Direct Ulta Beauty common stock after restricted grant

Option vesting schedule start March 15, 2027 First 25% tranche of options vests

Option vesting completion March 15, 2030 Final 25% tranche of options vests

Key Terms

restricted stock, Stock Option (right to buy), vesting, exercise price, +1 more

5 terms

restricted stock financial

"Represents grant of 519 shares of restricted stock, vesting 100% on March 15, 2029."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Option (right to buy) financial

"security_title: Stock Option (right to buy)"

vesting financial

"vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: 522.7100"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-03-31T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Ulta Beauty (ULTA) report for Christopher Lialios?

Ulta Beauty reported that SVP and Principal Accounting Officer Christopher Lialios received equity awards. He was granted 757 stock options and 519 restricted shares on March 31, 2026, increasing his directly held common stock to 3,550 shares.

How many Ulta Beauty shares did Christopher Lialios acquire in the latest Form 4?

Christopher Lialios acquired 519 shares of Ulta Beauty common stock as a restricted stock grant. These shares were awarded at no cash purchase price and increase his direct holdings to 3,550 common shares after the transaction.

What are the terms of Christopher Lialios’s new Ulta Beauty stock options?

Lialios received stock options covering 757 Ulta Beauty shares at a $522.71 exercise price. The options vest in 25% annual installments starting March 15, 2027 and on each anniversary through March 15, 2030, and expire on March 31, 2036.

When do Christopher Lialios’s Ulta Beauty restricted shares vest?

The 519 Ulta Beauty restricted shares granted to Christopher Lialios vest 100% on March 15, 2029. Until vesting, they remain subject to the grant’s restrictions but count as an equity-based compensation award reported in the Form 4.

Did Christopher Lialios buy or sell Ulta Beauty shares on the open market?

The filing shows no open-market buys or sells. Instead, Lialios received equity compensation: 757 stock options and 519 restricted shares granted at a $0 transaction price, reflecting compensation rather than market trading activity.

What is Christopher Lialios’s Ulta Beauty shareholding after these grants?

After the March 31, 2026 restricted stock grant, Lialios directly holds 3,550 Ulta Beauty common shares. He also holds options covering 757 additional shares, which become exercisable over time as they vest between 2027 and 2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 08:25 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lialios Christopher

(Last) (First) (Middle)

1000 REMINGTON BLVD., SUITE 120

(Street)

BOLINGBROOK ILLINOIS 60440

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Controller (P. Acct Ofc.)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		519(1)	A	$0	3,550	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$522.71	03/31/2026		A		757		(2)	03/31/2036	Common Stock	757	$0	757	D

Explanation of Responses:

1. Represents grant of 519 shares of restricted stock, vesting 100% on March 15, 2029.

2. The options, representing an initial right to purchase a total of 757 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.

	/s/ Rene G. Casares, as attorney-in-fact for Christopher Lialios	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)